What is the main business of Quercus Pharma?

The main business activity of Quercus Pharma focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 3, 2017.

Where is the headquarters located?

The headquarters is located at: ul. Frezerów 3, 20-209 Lublin.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $0 in 2024, which is an increase of 48.2% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $11,208. For comparison, in 2023 the loss was $2,696, meaning the company increased its loss by 294.9%.

Quercus Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2017-11-03

Share capital

5,000.00 PLN

Activity description

Quercus Pharma is the sole distributor in Poland of Yalodé cosmetics from Italy. Its range includes anti-wrinkle products, eye-care cosmetics, revitalizers, oils, and product sets.

Registered address

ul. Frezerów 3, 20-209 Lublin, Poland

Website

quercuspharma.com

Phone

Social media

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 562 days for 2023).

2025not filed
202406/11/2025
202328/01/2026
202230/06/2023
202104/10/2022
202012/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 0.42MedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -11.21kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 3.52kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 27.84kMedianUSD 608.93kAverageUSD 11.85m

Industry

Website technology

Website

WordPress

Authorized Representatives

Arkadiusz Tomasz Greszta – President of the Management Board

Manner of representation

The management board consists of 1 to 3 persons, including the President of the Management Board and Vice-Presidents of the Management Board. In the case of a multi-member management board, each member of the management board makes declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Arkadiusz Tomasz Gresztaage 52	50	$675.31	50%
Ireneusz Gresztaage 50	50	$675.31	50%

Arkadiusz Tomasz Greszta and Ireneusz Greszta hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2017-11-09.

Nest Bank
13 1870 1045 2078 1071 4436 0001
Nest Bank
53 1870 1045 2083 1071 4436 0001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Optimedussp. z o.o.	$1.00	optimedus.pl
Auditustechsp. z o.o.	$0.60	auditustech.com
Simplimedsp. z o.o.	$0.52	simplimed.pl
Prime Next Generationsp. z o.o.	$0.31	prime-next-generation.pl
Amarox Pharmasp. z o.o.	$0.31	amaroxpharma.pl
ITER Pharmasp. z o.o.	$0.17	iterpharma.pl
Novaovasp. z o.o.	$0.16	novaova.pl
Revital Medicasp. z o.o.	$0.10	revitalmedica.com.pl
Euro Eco Foodsp. z o.o.	$0.07	euroecofood.pl

FAQ

Last updated: 2026-04-26